Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty
Description
A prominent aspect of the post-coronavirus disease-2019 (post-COVID-19) era is long-COVID. Therefore, precise patient classification and exploration of the corresponding factors affecting long-COVID are crucial for tailored treatment strategies
